To investigate whether elevated FGF23-FGFR4 signaling might contribute to the cardiac metabolic remodeling observed in CKD, we studied cardiobundles, which are 3-dimensional multicellular cylindrical tissues bioengineered from NRVMs and fibroblasts. This evidence concerns the gene FGFR4 and chronic kidney disease.